Artemis Investment Management LLP
Position in MEDP — Medpace Holdings, Inc.
CIK 1535385
EDINBURGH, X0
Position in MEDP
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$19,951,244
+$8,421,883 QoQ
Shares Held
37,673
+56.9% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#85
of 691 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $254,068,544 across 6 Diagnostics & Research names. MEDP ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
467,921 | $99,175,855 | |
| 2 | NTRA |
Natera, Inc.
|
200,087 | $54,313,616 | |
| 3 | VCYT |
Veracyte, Inc.
|
638,933 | $37,524,535 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
115,993 | $22,412,167 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
41,270 | $20,691,127 | |
| 6 | MEDP |
Medpace Holdings, Inc.
This page
|
37,673 | $19,951,244 |
All Filings in MEDP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,951,244 | 37,673 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $11,529,361 | 24,010 | Shares | Sole | 2026-04-13 | |
| 2024-06-30 | $22,197,479 | 53,897 | Shares | Sole | 2024-07-15 | |
| 2022-12-31 | $4,426,199 | 20,838 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||